Home > News > Labopharm reports results for third quarter fiscal 2004
October 28th, 2004
Labopharm reports results for third quarter fiscal 2004
Abstract:
Labopharm Inc. (TSX: DDS) today reported its results for the third quarter of fiscal 2004 ended
September 30, 2004. Net loss for the third quarter of fiscal 2004 was $5.9 million, or $0.14
per share, compared with $7.9 million, or $0.22 per share, for the third quarter of fiscal 2003.
Source:
prnewswire
Bookmark:
| Related Links |
| Related News Press |
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||